BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 28159599)

  • 1. The Role of Acid Suppression in Barrett's Esophagus.
    Elias PS; Castell DO
    Am J Med; 2017 May; 130(5):525-529. PubMed ID: 28159599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Proton Pump Inhibitors on Barrett's Esophagus.
    Dunbar KB; Souza RF; Spechler SJ
    Gastroenterol Clin North Am; 2015 Jun; 44(2):415-24. PubMed ID: 26021202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of risk for Barrett's esophagus and esophageal adenocarcinoma.
    Thrift AP
    Curr Opin Gastroenterol; 2016 Jul; 32(4):319-24. PubMed ID: 27276368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local Synthesis of Pepsin in Barrett's Esophagus and the Role of Pepsin in Esophageal Adenocarcinoma.
    Samuels T; Hoekzema C; Gould J; Goldblatt M; Frelich M; Bosler M; Lee SH; Johnston N
    Ann Otol Rhinol Laryngol; 2015 Nov; 124(11):893-902. PubMed ID: 26077392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Barrett's esophagus regress after surgery (or proton pump inhibitors)?
    Spechler SJ
    Dig Dis; 2014; 32(1-2):156-63. PubMed ID: 24603402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reflux control is important in the management of Barrett's Esophagus: results from a retrospective 1,830 patient cohort.
    Brown CS; Lapin B; Wang C; Goldstein JL; Linn JG; Denham W; Haggerty SP; Talamonti MS; Howington JA; Carbray J; Ujiki MB
    Surg Endosc; 2015 Dec; 29(12):3528-34. PubMed ID: 25676204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rat Reflux Model of Esophageal Cancer and Its Implication in Human Disease.
    Greene CL; Worrell SG; DeMeester TR
    Ann Surg; 2015 Dec; 262(6):910-24. PubMed ID: 25822684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of chemoprevention with proton pump inhibitors in Barrett's esophagus.
    Sharaiha RZ; Freedberg DE; Abrams JA; Wang YC
    Dig Dis Sci; 2014 Jun; 59(6):1222-30. PubMed ID: 24795040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of surgical patients with gastroesophageal reflux disease and Barrett's esophagus].
    Zsolt S; Paszt A; Géczi T; Abrahám S; Tóth I; Horváth Z; Pieler J; Tajti J; Varga A; Tiszlavicz L; Németh I; Izbéki F; Rosztóczy A; Wittmann T; Lázár G
    Magy Seb; 2014 Oct; 67(5):287-96. PubMed ID: 25327403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bile reflux in benign and malignant Barrett's esophagus: effect of medical acid suppression and nissen fundoplication.
    Stein HJ; Kauer WK; Feussner H; Siewert JR
    J Gastrointest Surg; 1998; 2(4):333-41. PubMed ID: 9841990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting Proton Pump Inhibitors as Chemoprophylaxis Against the Progression of Barrett's Esophagus.
    Shah SL; Dunbar K
    Curr Gastroenterol Rep; 2023 Dec; 25(12):374-379. PubMed ID: 37940812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barrett's oesophagus and proton pump inhibitors: a pathological perspective.
    Shepherd NA
    Gut; 2000 Feb; 46(2):147-9. PubMed ID: 10644302
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy.
    Menges M; Müller M; Zeitz M
    Am J Gastroenterol; 2001 Feb; 96(2):331-7. PubMed ID: 11232672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acid suppression and surgical therapy for Barrett's oesophagus.
    de Jonge PJ; Spaander MC; Bruno MJ; Kuipers EJ
    Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):139-50. PubMed ID: 25743462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical Management of Barrett's Esophagus.
    Peyre CG; Watson TJ
    Gastroenterol Clin North Am; 2015 Jun; 44(2):459-71. PubMed ID: 26021205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Status of Chemoprevention in Barrett's Esophagus.
    Moayyedi P; El-Serag HB
    Gastrointest Endosc Clin N Am; 2021 Jan; 31(1):117-130. PubMed ID: 33213791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acid suppression medications reduce risk of oesophageal adenocarcinoma in Barrett's oesophagus: a nested case-control study in US male veterans.
    Tan MC; El-Serag HB; Yu X; Thrift AP
    Aliment Pharmacol Ther; 2018 Aug; 48(4):469-477. PubMed ID: 29956826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical treatment of Barrett's esophagus: can it prevent cancer?
    Sampliner RE
    Surg Oncol Clin N Am; 2009 Jul; 18(3):503-8. PubMed ID: 19500739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the treatment of proton pump inhibitors reduce dysplasia or adenocarcinoma development in Barrett's esophagus?
    Akın H; Aydın Y
    Turk J Gastroenterol; 2017 Dec; 28(Suppl 1):S31-S32. PubMed ID: 29199164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does antireflux surgery prevent progression of Barrett's esophagus?
    Lord RV
    Minerva Chir; 2011 Feb; 66(1):1-6. PubMed ID: 21389920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.